Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.20.4
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Dec. 31, 2020
Dec. 31, 2019
OPERATING EXPENSES    
General and administrative $ 2,641,470 $ 2,554,680
Research and development 2,019,924 1,227,686
TOTAL OPERATING EXPENSES 4,661,394 3,782,366
LOSS FROM OPERATIONS (4,661,394) (3,782,366)
OTHER INCOME (EXPENSE)    
Interest expense (9,737) (1,311)
Change in fair value of warrant liabilities 630,112 (694,134)
Loss on disposal of fixed asset 0 (3,230)
Equity in losses on equity method investment (25,412) (24,509)
Total other income (expenses), net 594,963 (723,184)
NET LOSS $ (4,066,431) $ (4,505,550)
BASIC AND DILUTED LOSS PER SHARE (in dollars per share) $ (0.18) $ (0.26)
WEIGHTED AVERAGE SHARES OUTSTANDING:    
BASIC AND DILUTED 23,174,168 17,071,678